Page 33 - Access Pool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

English News and Press Release on World about Health and Epidemic; published on 31 May 2021 by WHO

A dangerous gap is emerging between richer and poorer nations' recovery, and the longer we wait to act, the costlier action becomes in human suffering and economic losses.

A small number of pharmaceutical companies with the support of developed country governments invested billions of dollars in research and development of COVID-19 vaccines, related medicines, and technologies including mRNA, DNA, RNA, viral vector, protein subunit and testing materials along with their production and distribution.

I do not think that the waiver will help us overcoming the current vaccine shortage. The first problem is that there is not enough infrastructure – manufacturing facilities, equipment, personnel – to expand vaccine production to the levels it should be at to meet pandemic demand. In this context, altering the intellectual property status quo does little – Ana Santos Rutschman, assistant professor at the Saint Louis University School of Law pointed out in a conversation with Lénárd Sándor, researcher at the National University of Public Service. Ana Santos RUTSCHMAN is assistant p...

SCIENCE; (DATA) OUR WORLD IN DATA All told, 14 billion doses could leave factories before the year is over, according to a document written in advance of a March summit about stepping up the production pace. That's a startling number—before the pandemic, all of the world's vaccinemakers together produced at most 5.5 billion doses annually—and the document stresses that it's the best of all scenarios. “We have a set of manufacturing challenges that make it unlikely that we can meet the 14-billion aspiration,” cautions Lurie, who helped organize the meeting. Raw materials, such as dispo...